MicroVision shareholders approve increase in authorized common stock to 510M shares, elect all seven directors

MICROVISION, INC.

Authorized common stock increased to 510M shares (from prior amount) via Certificate of Amendment filed June 6, 2025.
Shareholders voted 145,459,632 for and 15,266,190 against the charter amendment; 65.66% of shares were represented.
All seven director nominees elected: Biddiscombe, Carlile, Herbst, Sharma, Schabert, Smith, Spitzer; each with >96M votes for.
2022 Equity Incentive Plan amendment approved (84,098,929 for, 19,032,357 against).
Advisory say-on-pay passed (82,683,644 for); Moss Adams/Baker Tilly ratified as auditor for FY2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MICROVISION, INC.: Increased authorized capital stock to 535,000,000 shares (510M common, 25M preferred) (effective 2025-06-06).

Change: charter amendment
Effective: 2025-06-06

Exact text from the filing

On June 6, 2025, MicroVision, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to increase the authorized number of shares of the Company’s capital stock to 535,000,000 shares, consisting of (i) 510,000,000 shares of common stock, $.001 par value (“Common Stock”) and (ii) 25,000,000 shares of preferred stock, $.001 par value. The Certificate of Amendment was effective upon the filing thereof with the Secretary of State of the State of Delaware.

View on SEC.gov

Browse all governance changes →

MICROVISION, INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-014015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.